Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

FACULTY

Andrea Pallotta, PharmD, BCPS
Infectious Diseases/HIV Clinical Specialist
Cleveland Clinic, OH

Michelle Rager, BA, PharmD
Associate Professor and Interim Department Chair of Pharmacy Practice
Shenandoah University – Bernard J. Dunn School of Pharmacy
Winchester, VA

FINANCIAL DISCLOSURE

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CE activity.

Disclosures of the following financial relationships have been provided:

Andrea Pallotta, PharmD, BCPS (Faculty)
Nothing to disclose
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

Michelle Rager, BA, PharmD (Faculty)
Nothing to disclose
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

Emily Scopelliti, PharmD, BCPS (Planning Committee-Peer Reviewer)
Nothing to disclose

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

ACCREDITATION STATEMENT & CREDIT DESIGNATION

Pharmacists
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity has been approved for 0.75 contact hours.

ACPE Universal Activity Number: 0396-0000-17-002-H04-P

Activity Type(s): Knowledge
Release Date: January 31, 2017
Expiration Date: January 31, 2018

Fee Information: There is no fee for this educational activity

Estimated time to complete activity: 45 minutes

TARGET AUDIENCE

This educational activity is designed for pharmacists in multiple settings who may assess, discuss, refer, and administer vaccinations to adults.

HOW TO EARN CREDIT

This activity will take approximately 45 minutes to complete. To receive credit, participants are required to complete the pre-test, view the online webinar and complete the post-test and evaluation forms.  Your post-test will be automatically graded. If you successfully complete the post-test (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the post-test. You will have 2 opportunities to pass the post-test. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

For questions, contact Laurie Novoryta with ACHL at 773-714-0705 or Lnovoryta@achlcme.org.

GOAL

The incidence of pneumococcal disease in the U.S. is highest in adults over the age of 65 years. These patients also have more serious disease and medical costs due to hospitalization than younger adults. However, rates of pneumococcal vaccinations in older adults are suboptimal and fall below established goals despite available recommendations and awareness campaigns. In light of their patient-centered focus and accessibility, pharmacists can play an integral in improving vaccination rates by counseling patients and ensuring receipt of recommended pneumococcal vaccines.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants will be able to:

• Discuss patient- and system-related barriers to achieving national standards for adult vaccinations
• Outline recommendations and schedules for pneumococcal vaccination in older and high-risk adults
• Formulate strategies to address patient questions and concerns about vaccination requirements
• Describe opportunities to expand the role of pharmacists in the administration of adult vaccines

REQUIRED COMPUTER HARDWARE/SOFTWARE

This site is best viewed with an HTML5 compatible browser; this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentations, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.

Disclosure of Unlabeled Use and Disclaimer

This CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers' prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support, as well as the ACPE Accreditation Standards for Continuing Pharmacy Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.